Information Provided By: 
Fly News Breaks for April 24, 2017
CVS
Apr 24, 2017 | 07:02 EDT
JPMorgan analyst Lisa Gill says she'd be a buyer of CVS Health shares ahead of the company's Q1 results. Near term concerns around retail segment performance and the broader Pharmacy Benefits Management business model have created a "compelling" valuation, Gill tells investors in a research note. She believes CVS is well positioned to drive continued innovation and benefit from changing market dynamics. The analyst keeps an Overweight rating on the shares with a $94 price target.
News For CVS From the Last 2 Days
There are no results for your query CVS
